229 related articles for article (PubMed ID: 16339304)
1. Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147.
Cotter PD; O'Connor PM; Draper LA; Lawton EM; Deegan LH; Hill C; Ross RP
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18584-9. PubMed ID: 16339304
[TBL] [Abstract][Full Text] [Related]
2. Homologues and bioengineered derivatives of LtnJ vary in ability to form D-alanine in the lantibiotic lacticin 3147.
Suda S; Lawton EM; Wistuba D; Cotter PD; Hill C; Ross RP
J Bacteriol; 2012 Feb; 194(3):708-14. PubMed ID: 22123251
[TBL] [Abstract][Full Text] [Related]
3. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity.
Xie L; Miller LM; Chatterjee C; Averin O; Kelleher NL; van der Donk WA
Science; 2004 Jan; 303(5658):679-81. PubMed ID: 14752162
[TBL] [Abstract][Full Text] [Related]
4. Lantibiotic Reductase LtnJ Substrate Selectivity Assessed with a Collection of Nisin Derivatives as Substrates.
Mu D; Montalbán-López M; Deng J; Kuipers OP
Appl Environ Microbiol; 2015 Jun; 81(11):3679-87. PubMed ID: 25795677
[TBL] [Abstract][Full Text] [Related]
5. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities.
Field D; Collins B; Cotter PD; Hill C; Ross RP
J Mol Microbiol Biotechnol; 2007; 13(4):226-34. PubMed ID: 17827973
[TBL] [Abstract][Full Text] [Related]
6. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
8. Lacticin 481 synthetase phosphorylates its substrate during lantibiotic production.
Chatterjee C; Miller LM; Leung YL; Xie L; Yi M; Kelleher NL; van der Donk WA
J Am Chem Soc; 2005 Nov; 127(44):15332-3. PubMed ID: 16262372
[TBL] [Abstract][Full Text] [Related]
9. Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147.
Liu W; Chan AS; Liu H; Cochrane SA; Vederas JC
J Am Chem Soc; 2011 Sep; 133(36):14216-9. PubMed ID: 21848315
[TBL] [Abstract][Full Text] [Related]
10. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
[TBL] [Abstract][Full Text] [Related]
11. In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide.
Skaugen M; Nissen-Meyer J; Jung G; Stevanovic S; Sletten K; Inger C; Abildgaard M; Nes IF
J Biol Chem; 1994 Nov; 269(44):27183-5. PubMed ID: 7961627
[TBL] [Abstract][Full Text] [Related]
12. Cell membrane damage induced by lacticin 3147 enhances aldehyde formation in Lactococcus lactis IFPL730.
Martínez-Cuesta MC; Requena T; Peláez C
Int J Food Microbiol; 2006 Jun; 109(3):198-204. PubMed ID: 16504327
[TBL] [Abstract][Full Text] [Related]
13. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives.
Kawulka KE; Sprules T; Diaper CM; Whittal RM; McKay RT; Mercier P; Zuber P; Vederas JC
Biochemistry; 2004 Mar; 43(12):3385-95. PubMed ID: 15035610
[TBL] [Abstract][Full Text] [Related]
14. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
15. Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.
Ryan MP; Jack RW; Josten M; Sahl HG; Jung G; Ross RP; Hill C
J Biol Chem; 1999 Dec; 274(53):37544-50. PubMed ID: 10608807
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lantibiotic lacticin 481 production at the transcriptional level by acid pH.
Hindré T; Le Pennec JP; Haras D; Dufour A
FEMS Microbiol Lett; 2004 Feb; 231(2):291-8. PubMed ID: 14987777
[TBL] [Abstract][Full Text] [Related]
17. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
18. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
[TBL] [Abstract][Full Text] [Related]
19. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
20. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.
Rink R; Kuipers A; de Boef E; Leenhouts KJ; Driessen AJ; Moll GN; Kuipers OP
Biochemistry; 2005 Jun; 44(24):8873-82. PubMed ID: 15952794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
